15th International Thyroid Congress
| Browse by: | Sort by: |
15th ITC Welcome Ceremony
Introduction
Robert C. Smallridge, MD
Mayo Clinic Jacksonville, Jacksonville, FL
Free
Unknown permission
for presentation
for presentation
15th ITC Welcome Ceremony
Introduction by ATA leadership, acknowledgement to all participating societies, acknowledgement to POC
John Armstrong, MD
Florida Department of Health, Tallahassee, FL
Free
Unknown permission
for presentation
for presentation
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Autoimmunity
Sandra M. McLachlan, PhD
Cedars-Sinai Medical Center, Los Angeles, CA
Free
All slides withheld
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Thyroid Cancer Neoplasm
Martin Schlumberger, MD
Institute Gustave-Roussy, Villejuif 94805 Cedex, France
Free
Slides + audio
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Thyroid Hormone Action
Douglas Forrest
National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD
Permission not
granted for presentation
granted for presentation
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Clinical Thyroidology
David S. Cooper
Johns Hopkins University School of Medicine, Baltimore, MD
Free
Slides + audio
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Molecular Mechanisms of MTC
Rui M. B. Maciel, MD, PhD
Federal University of Sao Paulo, Sao Paulo, Brazil
Free
Slides + audio
Coming soon
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Targeted Therapeutic Agents for MTC
Rossella Elisei, MD
University of Pisa, Pisa 56124, Italy
Free
Slides + audio
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Management of Side Effects of Long–Term Tyrosine Kinase Inhibitor Treatment
Barbara Jarzab, MD, PhD
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
Free
Unknown permission
for presentation
for presentation
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Update on MTC Guidelines
Samuel A. Wells, Jr., MD
National Cancer Institute NIH, Bethesda, MD
Free
Slides + audio
Opening Plenary Session: Advancing Individualized Medicine with Public–Private Partnerships
Introduction
Robert C. Smallridge, MD
Mayo Clinic Jacksonville, Jacksonville, FL
Free
Unknown permission
for presentation
for presentation
Opening Plenary Session: Advancing Individualized Medicine with Public–Private Partnerships
Symposium: New Concepts in the Management of Thyroid Nodules
Epidemiology of Benign Thyroid Nodules
Shuhang Xu, MD
Nanjing University of Traditional Chinese Medicine, Nanjing, Peoples Republic of China
Free
Slides + audio
Symposium: New Concepts in the Management of Thyroid Nodules
Risk/Benefits of Screening for Thyroid Nodules: Who Should Be Screened?
Arthur B. Schneider, MD, PhD
University of Illinois, Chicago, IL
Free
Unknown permission
for presentation
for presentation
Symposium: New Concepts in the Management of Thyroid Nodules
Benign Nodules: What next?
Susan J. Mandel, MD
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Free
Slides + audio
Coming soon
Symposium: Nontraditional TSHR Signaling
Selective TSHR Signaling by TSHR Antibodies
Terry F. Davies, MD, FRCP
Mount Sinai School of Medicine, New York, NY
Free
Slides + audio
Symposium: Nontraditional TSHR Signaling
TSHR–Arrestin–1 Mediated Pathways
Susanne E. Neumann, PhD
National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD
Permission not
granted for presentation
granted for presentation
Symposium: TR Alpha Mutations – Bench to Bedside
Animal Models
Sheue-yann Cheng, PhD
National Cancer Institute, NIH, Bethesda, MD
Free
Unknown permission
for presentation
for presentation
Symposium: TR Alpha Mutations – Bench to Bedside
Treatment of Animal Models
J.H. Duncan Bassett, MD, PhD
Imperial College London, London, United Kingdom
Permission not
granted for presentation
granted for presentation
Symposium: TR Alpha Mutations – Bench to Bedside
Human Mutations
Carla Moran, MB, ChB
University of Cambridge, Cambridge, United Kingdom
Free
Slides + audio
Symposium: TR Alpha Mutations – Bench to Bedside
Treatment of Patients
Robin P. Peeters, MD, PhD
Erasmus MC, Rotterdam, Rotterdam, Netherlands
Free
Slides + audio
Symposium: Thyroid Cancer – Translating Basic Science Discoveries to the Clinic
Redifferentiation of RAI–Refractory Thyroid Cancer
James A. Fagin, MD
Memorial Sloan-Kettering Cancer Center, New York, NY
Free
Slides + audio
Symposium: Thyroid Cancer – Translating Basic Science Discoveries to the Clinic
Somatic Mutations Analysis for Molecular Diagnosis
Yuri Nikiforov, MD, PhD
University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA
Free
Slides + audio
Coming soon
Symposium: Thyroid Cancer – Translating Basic Science Discoveries to the Clinic
Targeted Therapy
Sophie Leboulleux, MD, PhD
Service De Medecine Nucleair Et De Cancerologie Endocrinienne Institut, Villejuif, France
Free
Slides + audio
DD1 – Discussion/Debates Clinical: A Case-Based Discussion of International Hypothyroidism Guidelines
Gláucia M.F.S. Mazeto, MD, PhD
Sao Paulo State University - Unesp, Botucatu, Sao Paulo State, Brazil
Permission not
granted for presentation
granted for presentation
